Aurora Financial JournalOculis Holding AG (OCS)
NASDAQ · Health care · Pharmaceutical Preparations · Financial statements, TTM figures and earnings dates
Annual financial statements are available for fiscal years 2020 to 2025, taken from the company's filings with the SEC.
Open interactive financials →Key financials
| CHF | FY2025 2025-12-31 | FY2024 2024-12-31 | FY2023 2023-12-31 | FY2022 2022-12-31 | FY2021 2021-12-31 |
|---|---|---|---|---|---|
| Income statement | |||||
| Operating income | −CHF 81.7M | −CHF 73.2M | −CHF 80.7M | −CHF 32.4M | −CHF 13.2M |
| Net income | −CHF 99.0M | −CHF 85.8M | −CHF 88.8M | −CHF 38.7M | −CHF 18.6M |
| Diluted EPS | −CHF 1.89 | −CHF 2.12 | −CHF 2.97 | −CHF 11.32 | −CHF 5.84 |
| Cash flow | |||||
| Operating cash flow | −CHF 66.3M | −CHF 48.9M | −CHF 55.0M | −CHF 25.1M | −CHF 13.8M |
| Capital expenditure | CHF 301.0K | CHF 230.0K | CHF 48.0K | CHF 65.0K | CHF 28.0K |
| Free cash flow | −CHF 66.6M | −CHF 49.1M | −CHF 55.1M | −CHF 25.1M | −CHF 13.9M |
| Balance sheet | |||||
| Cash and equivalents | CHF 81.3M | CHF 27.7M | CHF 38.3M | CHF 19.8M | CHF 46.3M |
| Total assets | CHF 236.0M | CHF 120.4M | CHF 114.4M | CHF 37.1M | CHF 58.0M |
| Total liabilities | CHF 39.9M | CHF 47.0M | CHF 20.6M | CHF 135.1M | CHF 119.0M |
| Shareholders' equity | CHF 196.1M | CHF 73.4M | CHF 93.7M | −CHF 98.0M | −CHF 61.0M |
TTM = trailing twelve months (balance-sheet items at the latest quarter end). Figures in CHF as reported; per-share data adjusted for stock splits.
Annual reports
More on the interactive page
The full OCS page on Aurora Financial Journal includes every fiscal year since the company began filing structured data, income statement, balance sheet and cash flow statement line by line, the statements exactly as filed with the SEC, charts for every measure, valuation multiples (P/E, P/S, P/B), live price charts and the earnings calendar.
Open OCS financials →